Search by Drug Name or NDC

    NDC 69097-0949-03 Capecitabine 150 mg/1 Details

    Capecitabine 150 mg/1

    Capecitabine is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is CAPECITABINE.

    Product Information

    NDC 69097-0949
    Product ID 69097-949_c1549b67-948e-402d-9ba4-6fc16237df8f
    Associated GPIs 21300005000320
    GCN Sequence Number 039780
    GCN Sequence Number Description capecitabine TABLET 150 MG ORAL
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 31611
    HICL Sequence Number 018385
    HICL Sequence Number Description CAPECITABINE
    Brand/Generic Generic
    Proprietary Name Capecitabine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Capecitabine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name CAPECITABINE
    Labeler Name Cipla USA Inc.
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209365
    Listing Certified Through 2024-12-31

    Package

    NDC 69097-0949-03 (69097094903)

    NDC Package Code 69097-949-03
    Billing NDC 69097094903
    Package 60 TABLET, FILM COATED in 1 BOTTLE (69097-949-03)
    Marketing Start Date 2023-07-01
    NDC Exclude Flag N
    Pricing Information N/A